Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017037142) FOLDAMER HELIX BUNDLE-BASED MOLECULAR ENCAPSULATION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/037142 International Application No.: PCT/EP2016/070556
Publication Date: 09.03.2017 International Filing Date: 31.08.2016
IPC:
C07K 7/02 (2006.01) ,C08L 75/02 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
7
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
02
Linear peptides containing at least one abnormal peptide link
C CHEMISTRY; METALLURGY
08
ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
L
COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
75
Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
02
Polyureas
Applicants:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) [FR/FR]; 3, Rue Michel-Ange 75794 Paris, FR
UREKA SARL [FR/FR]; 5, Rue Du Rhone 68100 Mulhouse, FR
Inventors:
GUICHARD, Gilles; FR
COLLIE, Gavin; GB
PULKA-ZIACH, Karolina; PL
LOMBARDO, Caterina; IT
FREMAUX, Juliette; FR
Agent:
KASCHE, André; CH
Priority Data:
62/212,58331.08.2015US
Title (EN) FOLDAMER HELIX BUNDLE-BASED MOLECULAR ENCAPSULATION
(FR) ENCAPSULATION MOLÉCULAIRE FONDÉE SUR DES FAISCEAUX HÉLICOÏDAUX DE FOLDAMÈRES
Abstract:
(EN) The present description provides compositions and methods for producing therapeutic oligomeric compounds. In another aspect the description provides methods for administering the oligomeric compounds for the treatment and prevention of disease in a mammal. In particular, the disclosure relates to medicaments comprising various novel oligomeric compounds and pharmaceutically acceptable salts thereof. The compounds of the disclosure may optionally be administered with at least one of a pharmaceutically acceptable excipient, additional pharmacologically active agent or a combination thereof.
(FR) La présente invention porte sur des compositions et des procédés pour la production de composés oligomères thérapeutiques. Selon un autre aspect, l'invention porte sur des procédés pour l'administration de ces composés oligomères à des fins de traitement et de prévention d'une maladie chez un mammifère. En particulier, l'invention porte sur des médicaments comprenant divers nouveaux composés oligomères et leurs sels de qualité pharmaceutique. Les composés selon l'invention peuvent éventuellement être administrés avec au moins un excipient de qualité pharmaceutique, un principe pharmacologiquement actif supplémentaire ou une combinaison de ceux-ci.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)